Published in Gut on September 01, 2004
Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72
Induction of TLR-2 and TLR-5 expression by Helicobacter pylori switches cagPAI-dependent signalling leading to the secretion of IL-8 and TNF-α. PLoS One (2011) 2.29
Helicobacter pylori genome evolution during human infection. Proc Natl Acad Sci U S A (2011) 2.15
Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev (2006) 1.73
Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet (2016) 1.60
Kyoto global consensus report on Helicobacter pylori gastritis. Gut (2015) 1.47
Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent manner. PLoS One (2010) 1.35
Helicobacter pylori virulence and cancer pathogenesis. Future Oncol (2014) 1.21
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology (2015) 1.21
Gastroenteritis and transmission of Helicobacter pylori infection in households. Emerg Infect Dis (2006) 1.18
Pathogenesis of Helicobacter pylori-Related Gastroduodenal Diseases from Molecular Epidemiological Studies. Gastroenterol Res Pract (2012) 1.17
The significance of virulence factors in Helicobacter pylori. J Dig Dis (2013) 1.16
Vaccinating against Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol (2011) 1.14
Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol (2013) 1.09
Genetic analysis of Helicobacter pylori strain populations colonizing the stomach at different times postinfection. J Bacteriol (2007) 1.09
Helicobacter pylori colonization critically depends on postprandial gastric conditions. Sci Rep (2012) 0.99
Slow genetic divergence of Helicobacter pylori strains during long-term colonization. Infect Immun (2005) 0.98
Hyperendemic H. pylori and tapeworm infections in a U.S.-Mexico border population. Public Health Rep (2010) 0.91
Friend and foe: factors influencing the movement of the bacterium Helicobacter pylori along the parasitism-mutualism continuum. Evol Appl (2014) 0.91
Immune responses to Helicobacter pylori infection. World J Gastroenterol (2014) 0.90
H. pylori vaccines: why we still don't have any. Hum Vaccin (2011) 0.90
Systemic cytokine levels and subsequent risk of gastric cancer in Chinese Women. Cancer Sci (2011) 0.89
In vivo sequence variation in HopZ, a phase-variable outer membrane protein of Helicobacter pylori. Infect Immun (2012) 0.88
B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun (2005) 0.87
Helicobacter pylori infection in a pig model is dominated by Th1 and cytotoxic CD8+ T cell responses. Infect Immun (2013) 0.87
Failure to detect Helicobacter pylori DNA in drinking and environmental water in Dhaka, Bangladesh, using highly sensitive real-time PCR assays. Appl Environ Microbiol (2009) 0.86
Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan. J Gastroenterol Hepatol (2014) 0.86
Diffuse duodenal nodular lymphoid hyperplasia: a large cohort of patients etiologically related to Helicobacter pylori infection. BMC Gastroenterol (2011) 0.83
Impact of cagPAI and T4SS on the inflammatory response of human neutrophils to Helicobacter pylori infection. PLoS One (2013) 0.82
Helicobacter pylori infection and gastroesophageal cancer: unveiling a Hamletic dilemma. Ann Gastroenterol (2014) 0.82
Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease. Expert Rev Gastroenterol Hepatol (2015) 0.81
Acquisition of Helicobacter pylori infection in rhesus macaques is most consistent with oral-oral transmission. J Clin Microbiol (2006) 0.81
Unintended consequences of Helicobacter pylori infection in children in developing countries: iron deficiency, diarrhea, and growth retardation. Gut Microbes (2013) 0.81
Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity. Infect Immun (2009) 0.81
Vaccinating against Helicobacter pylori in the developing world. Gut Microbes (2013) 0.80
Novel insights on the role of CD8+ T cells and cytotoxic responses during Helicobacter pylori infection. Gut Microbes (2014) 0.79
Association of presence/absence and on/off patterns of Helicobacter pylori oipA gene with peptic ulcer disease and gastric cancer risks: a meta-analysis. BMC Infect Dis (2013) 0.79
Genetic determinants and clinico-pathological outcomes of helicobacter pylori infection. Ann Ib Postgrad Med (2014) 0.78
Experimental Helicobacter pylori infection in humans: a multifaceted challenge. Gut (2004) 0.77
Immunoprevalence to Six Waterborne Pathogens in Beachgoers at Boquerón Beach, Puerto Rico: Application of a Microsphere-Based Salivary Antibody Multiplex Immunoassay. Front Public Health (2017) 0.75
Population screening and treatment of Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol (2017) 0.75
Identification of Helicobacter pylori and the evolution of an efficacious childhood vaccine to protect against gastritis and peptic ulcer disease. Pediatr Res (2016) 0.75
Helicobacter pylori overcomes natural immunity in repeated infections. Clin Case Rep (2016) 0.75
Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol (2016) 0.75
Irregular Meal Timing Is Associated with Helicobacter pylori Infection and Gastritis. ISRN Nutr (2012) 0.75
Helicobacter pylori-Mediated Protection against Extra-Gastric Immune and Inflammatory Disorders: The Evidence and Controversies. Diseases (2015) 0.75
Interaction of Ethnicity and H. pylori Infection in the Occurrence of Microscopic Colitis. Dig Dis Sci (2017) 0.75
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A (1996) 16.69
Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust (1985) 10.75
Research on dengue during World War II. Am J Trop Med Hyg (1952) 8.76
Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol (1987) 7.09
Experimental Campylobacter jejuni infection in humans. J Infect Dis (1988) 7.05
Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A (1999) 4.55
Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol (1999) 4.13
Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol (2001) 3.75
A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A (2000) 3.66
Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol (1996) 3.57
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol (1971) 3.33
Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol (1998) 3.31
Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India. J Bacteriol (2000) 2.81
Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA (1999) 2.67
Typhoid fever: pathogenesis and immunologic control. 2. N Engl J Med (1970) 2.63
Helicobacter pylori in North and South America before Columbus. FEBS Lett (2002) 2.57
Studies on Q fever in man. Trans Assoc Am Physicians (1956) 2.52
Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter (1998) 2.39
Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc (1994) 2.36
Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol (1994) 2.16
The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med (2000) 2.02
Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol (1988) 1.97
Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis (1995) 1.97
Helicobacter pylori infection in mice: Role of outer membrane proteins in colonization and inflammation. Gastroenterology (2002) 1.58
Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun (1998) 1.54
Long-term follow-up of voluntary ingestion of Helicobacter pylori. Ann Intern Med (1991) 1.49
Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infect Immun (1998) 1.38
Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am J Trop Med Hyg (1992) 1.38
Clinical and serologic responses of volunteers infected with phlebotomus fever virus (Sicilian type). Am J Trop Med Hyg (1976) 1.37
Immunisation against gastric infection with Helicobacter species: first step in the prophylaxis of gastric cancer? Zentralbl Bakteriol (1993) 1.27
Oral immunization against Helicobacter pylori. Infect Immun (1991) 1.27
Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection. Vaccine (1997) 1.26
Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol (1999) 1.24
Natural history of Helicobacter pylori infection in childhood: 12-year follow-up cohort study in a biracial community. Clin Infect Dis (1999) 1.20
Isolation of Helicobacter pylori from vomitus in children and its implication in gastro-oral transmission. Am J Gastroenterol (1999) 1.13
Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection. Microbiol Immunol (2000) 1.06
A new triple stain for Helicobacter pylori suitable for the autostainer: carbol fuchsin/Alcian blue/hematoxylin-eosin. Arch Pathol Lab Med (1998) 1.06
Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. Vaccine (1999) 1.00
Confirmation of successful therapy of Helicobacter pylori infection: number and site of biopsies or a rapid urease test. Am J Gastroenterol (1995) 1.00
The best gastric site for obtaining a positive rapid ureas test. Helicobacter (1996) 0.97
Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis. Immunology (1998) 0.97
Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii. Infect Immun (2001) 0.96
New strategies for the prevention and treatment of Helicobacter pylori infection. Expert Opin Investig Drugs (2002) 0.86
Antimicrobial therapy of peptic ulcers. Int J Antimicrob Agents (1997) 0.83
A comparison of murine and human immunoproteomes of Helicobacter pylori validates the preclinical murine infection model for antigen screening. Infect Immun (2002) 0.81
Working towards a Helicobacter pylori vaccine. Gastroenterology (1999) 0.79
Towards the development of vaccines against Helicobacter pylori: status and issues. Curr Opin Investig Drugs (2001) 0.77
Cross-national epidemiology of major depression and bipolar disorder. JAMA (1996) 7.98
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet (2000) 5.26
Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02
Norwalk virus infection of volunteers: new insights based on improved assays. J Infect Dis (1994) 4.37
Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science (1974) 3.86
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med (2000) 3.78
A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg (1973) 3.71
Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology (2000) 3.42
Segmental pedicle screw fixation in the treatment of thoracic idiopathic scoliosis. Spine (Phila Pa 1976) (1995) 3.39
Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis. J Infect Dis (1978) 3.32
Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res (2001) 3.18
Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet (2001) 3.09
Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet (1991) 3.09
Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg (1974) 2.95
Immunoglobulin M antibody capture enzyme-linked immunosorbent assay for diagnosis of St. Louis encephalitis. J Clin Microbiol (1984) 2.95
Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med (1987) 2.83
Essential role of STAT3 for embryonic stem cell pluripotency. Proc Natl Acad Sci U S A (1999) 2.74
The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. J Clin Psychiatry (1994) 2.73
Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology (1999) 2.72
Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med (1998) 2.70
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology (1999) 2.62
Chlamydia trachomatis infant pneumonitis: comparison with matched controls and other infant pneumonitis. N Engl J Med (1978) 2.60
Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet (1987) 2.59
Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology (1999) 2.54
Prevalence of suicide ideation and suicide attempts in nine countries. Psychol Med (1999) 2.50
Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother (1997) 2.47
Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Mol Cell (2000) 2.41
Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates. Clin Infect Dis (1998) 2.38
Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ (1981) 2.36
Lassa fever. Trop Doct (1973) 2.32
Adding posterior lumbar interbody fusion to pedicle screw fixation and posterolateral fusion after decompression in spondylolytic spondylolisthesis. Spine (Phila Pa 1976) (1997) 2.26
Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J Virol (1986) 2.26
Type I IFN modulates innate and specific antiviral immunity. J Immunol (2000) 2.26
Regulatory effect of pyruvate on the glucose metabolism of Clostridium thermosaccharolyticum. J Bacteriol (1967) 2.15
Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun (1999) 2.14
Effect of age on the frequency of active Campylobacter pylori infection diagnosed by the [13C]urea breath test in normal subjects and patients with peptic ulcer disease. J Infect Dis (1988) 2.01
A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine (1997) 1.99
Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect (2000) 1.97
Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis (1995) 1.97
New simple technique for hepatic parenchymal resection using a Cavitron Ultrasonic Surgical Aspirator and bipolar cautery equipped with a channel for water dripping. World J Surg (1999) 1.96
Helicobacter pylori in the drinking water in Peru. Gastroenterology (1996) 1.95
Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies. Am J Trop Med Hyg (1974) 1.92
Leakage of cement in percutaneous transpedicular vertebroplasty for painful osteoporotic compression fractures. J Bone Joint Surg Br (2003) 1.91
Clinical presentation of Lassa fever cases during the hospital epidemic at Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg (1973) 1.91
Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1. Cell Death Differ (2005) 1.89
Surgical techniques and innovations in living related liver transplantation. Ann Surg (1993) 1.88
Thermolabile in vivo DNA-binding activity associated with a protein encoded by mutants of herpes simplex virus type 1. J Virol (1983) 1.86
Lassa fever: review of epidemiology and epizootiology. Bull World Health Organ (1975) 1.86
Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology (1996) 1.84
Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem (1999) 1.83
Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet (1991) 1.82
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol (2000) 1.79
Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation. AJNR Am J Neuroradiol (2008) 1.79
The 1970 yellow fever epidemic in Okwoga District, Benue Plateau State, Nigeria. 3. Serological responses in persons with and without pre-existing heterologous group B immunity. Bull World Health Organ (1973) 1.79
Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood (2000) 1.76
The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. J Immunol (1998) 1.75
In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation. Antimicrob Agents Chemother (1978) 1.74
Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology (1989) 1.74
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol (2001) 1.73
Lassa fever in Britain: an imported case. Br Med J (1973) 1.72
Osteoconduction at porous hydroxyapatite with various pore configurations. Biomaterials (2000) 1.71
Lumbosacral spinal fusion. A biomechanical study. Spine (Phila Pa 1976) (1984) 1.69
Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother (2001) 1.68
Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology (2000) 1.65
Etiology of Crohn's disease: the role of Mycobacterium avium paratuberculosis. Trends Mol Med (2001) 1.65
Persistent infection of mouse fibroblasts (McCoy cells) with a trachoma strain of Chlamydia trachomatis. Infect Immun (1981) 1.64
Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut (2005) 1.62
The cross-national epidemiology of panic disorder. Arch Gen Psychiatry (1997) 1.61
[An epidemiological study of purulent meningitis cases admitted to hospital in Dakar, 1970-1979]. Bull World Health Organ (1981) 1.61
Comparison of Cotrel-Dubousset pedicle screws and hooks in the treatment of idiopathic scoliosis. Int Orthop (1994) 1.61
Transient anisocoria secondary to nebulized ipratropium bromide. Clin Pediatr (Phila) (1998) 1.60
Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. Br J Cancer (2013) 1.60
Lassa fever and Marburg virus disease. WHO Chron (1974) 1.58
Interaction between a trachoma strain of Chlamydia trachomatis and mouse fibroblasts (McCoy cells) in the absence of centrifugation. Infect Immun (1981) 1.58
Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperthermia (2005) 1.56
Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy. Lab Invest (1983) 1.55
Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun (1998) 1.54
Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection. Aliment Pharmacol Ther (2006) 1.54
H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter (1998) 1.52
In vivo susceptibility of Campylobacter pylori. Am J Gastroenterol (1989) 1.52
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States. Dig Liver Dis (2004) 1.51
Pneumococcal serotypes in West Africa. Lancet (1980) 1.51
Labile serum factor and its effect on arbovirus neutralization. Appl Microbiol (1971) 1.51
Suppression of tumor necrosis factor-alpha production and neutrophil infiltration during ischemia-reperfusion injury of the liver after heat shock preconditioning. J Hepatol (2001) 1.50
Detection of yellow fever virus in serum by enzyme immunoassay. Am J Trop Med Hyg (1984) 1.50
Genetic variation among dengue 2 viruses of different geographic origin. Virology (1983) 1.48
Arthropod-borne encephalitides in the Americas. Bull World Health Organ (1979) 1.47
Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol Lett (1994) 1.47
Alcoholism--North America and Asia. A comparison of population surveys with the Diagnostic Interview Schedule. Arch Gen Psychiatry (1990) 1.47
In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med (1995) 1.46
Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter (2000) 1.46
Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans. Am J Epidemiol (1971) 1.45